These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18671934)

  • 1. Proprotein convertase activation of aggrecanases in cartilage in situ.
    Malfait AM; Arner EC; Song RH; Alston JT; Markosyan S; Staten N; Yang Z; Griggs DW; Tortorella MD
    Arch Biochem Biophys; 2008 Oct; 478(1):43-51. PubMed ID: 18671934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggrecanase and aggrecan degradation in osteoarthritis: a review.
    Huang K; Wu LD
    J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.
    Verma P; Dalal K
    J Cell Biochem; 2011 Dec; 112(12):3507-14. PubMed ID: 21815191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cleavage of biglycan by aggrecanases.
    Melching LI; Fisher WD; Lee ER; Mort JS; Roughley PJ
    Osteoarthritis Cartilage; 2006 Nov; 14(11):1147-54. PubMed ID: 16806997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.
    Song RH; Tortorella MD; Malfait AM; Alston JT; Yang Z; Arner EC; Griggs DW
    Arthritis Rheum; 2007 Feb; 56(2):575-85. PubMed ID: 17265492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggrecanases in the human synovial fluid at different stages of osteoarthritis.
    Zhang E; Yan X; Zhang M; Chang X; Bai Z; He Y; Yuan Z
    Clin Rheumatol; 2013 Jun; 32(6):797-803. PubMed ID: 23370724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggrecanases and cartilage matrix degradation.
    Nagase H; Kashiwagi M
    Arthritis Res Ther; 2003; 5(2):94-103. PubMed ID: 12718749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of aggrecanase: a novel protective mechanism of dehydroepiandrosterone in osteoarthritis?
    Huang K; Wu LD
    Mol Biol Rep; 2010 Mar; 37(3):1241-5. PubMed ID: 19277895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.
    Malfait AM; Liu RQ; Ijiri K; Komiya S; Tortorella MD
    J Biol Chem; 2002 Jun; 277(25):22201-8. PubMed ID: 11956193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aggrecanases and osteoarthritis].
    Li C; Cao YP; Guan ZP; Huang de Y; Ge ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):611-2. PubMed ID: 19829688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.
    Stanton H; Rogerson FM; East CJ; Golub SB; Lawlor KE; Meeker CT; Little CB; Last K; Farmer PJ; Campbell IK; Fourie AM; Fosang AJ
    Nature; 2005 Mar; 434(7033):648-52. PubMed ID: 15800625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review.
    Bondeson J; Wainwright S; Hughes C; Caterson B
    Clin Exp Rheumatol; 2008; 26(1):139-45. PubMed ID: 18328163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulated cell surface zymogen activation of the proprotein convertase PC5A directs the processing of its secretory substrates.
    Mayer G; Hamelin J; Asselin MC; Pasquato A; Marcinkiewicz E; Tang M; Tabibzadeh S; Seidah NG
    J Biol Chem; 2008 Jan; 283(4):2373-84. PubMed ID: 18039650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage.
    Naito S; Shiomi T; Okada A; Kimura T; Chijiiwa M; Fujita Y; Yatabe T; Komiya K; Enomoto H; Fujikawa K; Okada Y
    Pathol Int; 2007 Nov; 57(11):703-11. PubMed ID: 17922681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation.
    Cheung KS; Hashimoto K; Yamada N; Roach HI
    Rheumatol Int; 2009 Mar; 29(5):525-34. PubMed ID: 18941754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms.
    Tortorella MD; Arner EC; Hills R; Gormley J; Fok K; Pegg L; Munie G; Malfait AM
    Arch Biochem Biophys; 2005 Dec; 444(1):34-44. PubMed ID: 16289022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of aggrecanase 1 in Lyme arthritis.
    Behera AK; Hildebrand E; Szafranski J; Hung HH; Grodzinsky AJ; Lafyatis R; Koch AE; Kalish R; Perides G; Steere AC; Hu LT
    Arthritis Rheum; 2006 Oct; 54(10):3319-29. PubMed ID: 17009305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of human neutralizing antibody to ADAMTS4 (aggrecanase-1) and ADAMTS5 (aggrecanase-2).
    Shiraishi A; Mochizuki S; Miyakoshi A; Kojoh K; Okada Y
    Biochem Biophys Res Commun; 2016 Jan; 469(1):62-69. PubMed ID: 26612259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCN1 (Cyr61) Is Overexpressed in Human Osteoarthritic Cartilage and Inhibits ADAMTS-4 (Aggrecanase 1) Activity.
    Chijiiwa M; Mochizuki S; Kimura T; Abe H; Tanaka Y; Fujii Y; Shimizu H; Enomoto H; Toyama Y; Okada Y
    Arthritis Rheumatol; 2015 Jun; 67(6):1557-67. PubMed ID: 25709087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.
    Troeberg L; Fushimi K; Khokha R; Emonard H; Ghosh P; Nagase H
    FASEB J; 2008 Oct; 22(10):3515-24. PubMed ID: 18632849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.